USPTO Patent Granted for Oral Care Compositions
Summary
The USPTO has granted a patent to Colgate-Palmolive Company for new oral care compositions and methods of use. The patent covers formulations containing precipitated calcium carbonate and synergistic preservative combinations.
What changed
The United States Patent and Trademark Office (USPTO) has granted patent US12582582B2 to Colgate-Palmolive Company for "Oral care compositions and methods of use." This patent specifically covers improved oral care formulations that include precipitated calcium carbonate (PCC) and synergistic preservative combinations, along with methods for their preparation and application.
This is a patent grant, which provides intellectual property protection for the assignee's innovation. While not a regulatory mandate for other entities, it signifies a new development in oral care product technology. Companies operating in the pharmaceutical or consumer goods sectors, particularly those involved in oral hygiene products, should be aware of this patent as it may impact their product development and market strategies.
Source document (simplified)
Oral care compositions and methods of use
Grant US12582582B2 Kind: B2 Mar 24, 2026
Assignee
Colgate-Palmolive Company
Inventors
Marcella Mourao, Enzo Utima, Tatiana Cinquetti
Abstract
Disclosed herein are improved oral care formulations comprising precipitated calcium carbonate (PCC) and synergistic preservative combinations selected. Methods of making and using the compositions are also provided.
CPC Classifications
A61K 8/19 A61K 8/34 A61K 8/345 A61Q 11/00
Filing Date
2021-08-06
Application No.
17396102
Claims
11
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.